
GC65146
BMS-816336
Also known as 1-(3-hydroxyazetidin-1-yl)-2-(6-hydroxy-2-phenyl-2-adamantyl)ethanone
BMS-816336 is a novel, potent and orally bioavailable inhibitor against human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) enzyme with an IC50 of 3·0 nM
ChemicalCAS1009583-20-3MW341.44FormulaC21H27NO3
- CAS number
- 1009583-20-3
- Molecular weight
- 341.44
- Formula
- C21H27NO3
- Solubility
- DMSO : 300 mg/mL (878·63 mM; Need ultrasonic)
- InChIKey
- OAAZMUGLOXGVNH-UHFFFAOYSA-N
- Catalogue number
- GC65146
- Brand
- GLPBIO
Computed properties PubChem CID 59336911 · XLogP 1.7 · TPSA 60.8 Ų · H-bond donors 2
- XLogP
- 1.7
- TPSA
- 60.8 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 3
- Heavy atoms
- 25
SMILES C1C2CC3CC(C2O)CC1C3(CC(=O)N4CC(C4)O)C5=CC=CC=C5
Computed descriptors from PubChem (CID 59336911), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il